As of June 30, 2026, Eli Lilly (NYSE: LLY) was held by 30 hedge funds, which collectively reduced their aggregate holdings by approximately 125.8 million shares, from 130.9 million to 5 million. This represents a decline of 96.16% in shares held compared to the previous reporting period ending March 31, 2026.
Among those funds, Citigroup Inc. notably increased its position by 172,770 shares, with a market value change of approximately $370,000. Conversely, AmeriServ Wealth Advisors and Eurizon SLJ Capital Ltd both reported decreases in their share counts, with reductions of 42 and 382 shares, respectively. The overall market value attributed to LLY holdings across the funds increased by around $834,536 despite the significant decline in the number of shares held.
This trend highlights a significant shift in the sentiment of hedge fund managers regarding Eli Lilly, emphasizing the importance of examining aggregate data from 13F filings over individual positions to better understand market movements.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
